Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug4373 | anti-SARS-CoV-2 convalescent plasma Wiki | 0.50 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
The purpose of this research study is to learn more about how mindfulness training may influence thinking and feeling.
Description: 5FMQ is a 15-item questionnaire with 5 sub-scales: observing, describing, acting with awareness, non-judgmental inner experience, and non-reactivity. The score for each sub-scale ranges from 3 to 15, a higher score is indicative of greater mindfulness skills.
Measure: Change in mindfulness skills as measured by Five-Facet Mindfulness Questionnaire (5FMQ) Time: Baseline to week 10Description: EQ Decentering is an 11-item sub-scale measuring various thoughts and experiences, and the tendency to distance from those. The decentering score ranges from 1 to 55, with a higher score indicating high level of decentering.
Measure: Change in mindfulness skills as measured by decentering - Experiences Questionnaire (EQ). Time: Baseline to week 10Description: PHQ4 is an ultra-brief 4-item measure of depression and anxiety with the total score ranging from 0 to 12. Higher score indicates higher level of anxiety and depression.
Measure: Change in psychological health as measured by Patient Health Questionnaire 4 items (PHQ4). Time: Baseline to week 10Description: The PANAS positive sub-scale includes 5 items with a score ranges from 5 to 25 with a higher score indicating a higher positive mood.
Measure: Change in positive affect on psychological health as measured by the short variant of the Positive and Negative Affect Scale (PANAS). Time: Baseline to week 10Description: The PANAS negative sub-scale includes 5 items with a score ranges from 5 to 25 with a higher score indicating a higher negative mood.
Measure: Change in negative affect on psychological health as measured by the short variant of the Positive and Negative Affect Scale (PANAS). Time: Baseline to week 10Description: The 3 loneliness questions from the social isolation battery will be used to measure loneliness with each question has a score ranging from 1 to 3 and a higher score indicates more loneliness.
Measure: Change in loneliness measured by the loneliness questions from the social isolation battery. Time: Baseline to week 10Description: The loneliness question will be used to measure perceived loneliness with a score ranging from 1 to 7 and a higher score indicates more loneliness.
Measure: Change in loneliness measured by a loneliness question. Time: Baseline to week 10Description: Attention is measured by using the Sustained Attention Response Task that involves pressing a button to frequently presented non-target trials (numbers 1, 2, 4, 5, 6, 7, 8, and 9) and withholding the button press to the infrequent target trials (number 3). The score (A prime) is calculated by considering accuracy on both non-target and target trials with a score maximum of 1. A higher score indicates better attentional performance.
Measure: Change in attention Time: Baseline to week 10Description: PTQ is a 15-item questionnaire indexing the occurrence of negative thinking. The total PTQ score range is from 0 to 60, with a higher score indicating a frequent occurrence of negative thoughts.
Measure: Change in well-being as measured by the Perseverative Thought Questionnaire (PTQ) Time: Baseline to week 10Description: The EIS is a 5-item questionnaire indexing the impact of intrusive thoughts regarding an emotional event with a score ranging from 0 to 20. A higher score indicating a higher level of intrusions.
Measure: Change in well-being as measured by the Experience of Intrusions Scale (EIS) Time: Baseline to week 10Description: The short version of PSS is a 4-item questionnaire measuring the degree to which situations in one's life are viewed as stressful within the past month. The total score ranges from 0 to 16. A higher score indicates higher level of perceived stress.
Measure: Change in well-being as measured by the short version of the perceived stress scale (PSS). Time: Baseline to week 10Description: PERMA-Profiler a 15-item multidimensional measure used to index well-being according to the following 5 dimensions: positive emotions, engagement, relationships, meaning, and accomplishments. The score for each subscale range from 0 to 10, with a higher score indicating better well-being.
Measure: Change in well-being as measured by the PERMA-Profiler Time: Baseline to week 10Alphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports